WallStreetZenWallStreetZen

NASDAQ: AXDX
Accelerate Diagnostics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

AXDX past revenue growth

How has AXDX's revenue growth performed historically?
Company
-5.43%
Industry
9.39%
Market
17.61%
AXDX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
AXDX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
AXDX's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

AXDX earnings and revenue history

Current Revenue
$12.1M
Current Earnings
-$61.6M
Current Profit Margin
-511%

AXDX Return on Equity

Insufficient data to display

Be the first to know when AXDX announces earnings.

AXDX Return on Assets

Current Company
-143.7%
Current Industry
5.3%
AXDX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

AXDX Return on Capital Employed

Current Company
-274.29%
Current Industry
8.3%
AXDX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AXDX vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
AXDX$12.06M-$49.77M-$61.62M+16.29%N/A
BSGM$18.00k-$28.39M-$29.05M-79.80%N/A
QTI$40.36k-$5.08M-$6.10M-66.76%N/A
PAVM$2.45M-$60.35M-$66.27M+121.45%N/A
SSKN$33.36M-$3.38M-$10.83M+2.24%N/A
View Top Medical Device Stocks

AXDX earnings dates

Next earnings date
May 9, 2024

Accelerate Diagnostics Earnings & Revenue FAQ

What were AXDX's earnings last quarter?

On Invalid Date, Accelerate Diagnostics (NASDAQ: AXDX) reported Q4 2023 earnings per share (EPS) of -$0.81, up 42.14% year over year. Total Accelerate Diagnostics earnings for the quarter were -$13.00 million. In the same quarter last year, Accelerate Diagnostics's earnings per share (EPS) was -$1.40.

If you're new to stock investing, here's how to buy Accelerate Diagnostics stock.

What was AXDX's earnings growth in the past year?

As of Q2 2024, Accelerate Diagnostics's earnings has grown year over year. Accelerate Diagnostics's earnings in the past year totalled -$61.62 million.

What is AXDX's earnings date?

Accelerate Diagnostics's earnings date is Invalid Date. Add AXDX to your watchlist to be reminded of AXDX's next earnings announcement.

What was AXDX's revenue last quarter?

On Invalid Date, Accelerate Diagnostics (NASDAQ: AXDX) reported Q4 2023 revenue of $3.03 million up 1.85% year over year. In the same quarter last year, Accelerate Diagnostics's revenue was $2.97 million.

What was AXDX's revenue growth in the past year?

As of Q2 2024, Accelerate Diagnostics's revenue has grown -5.43% year over year. This is 14.82 percentage points lower than the US Medical Devices industry revenue growth rate of 9.39%. Accelerate Diagnostics's revenue in the past year totalled $12.06 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.